SMA
EUCRU

Sage Mountain Advisors’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Sage Mountain Advisors’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
2022
Q2 		$860K Sell
2022
Q1 		$933K Sell
2021
Q4 		$964K Sell
2021
Q3 		$977K Buy
2021
Q2 		$979K Hold
2021
Q1 		$965K Hold
2020
Q4 		$1.02M Buy